Eiko LifeSciences Limited (BOM:540204)

India · Delayed Price · Currency is INR

53.31

+0.28 (0.53%)

At close: May 27, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Speciality Chemicals & Pharma Intermediates		-	279.29M	183.21M	260.54M	124.01M
Speciality Chemicals & Pharma Intermediates Growth		-	52.44%	-29.68%	110.11%	19.12%
Total		-	279.29M	183.21M	260.54M	124.01M
Total Growth		-	52.44%	-29.68%	110.11%	19.12%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
India		357.36M	279.29M	179.76M	236.76M	75.55M
India Growth		27.95%	55.37%	-24.07%	213.37%	-27.43%
Export		2.96M	-	3.42M	17.36M	44.35M
Export Growth		-	-	-80.32%	-60.85%	-
Unallocated		16.32M	-	36.00K	205.00K	-
Unallocated Growth		-	-	-82.44%	-	-
Total		376.64M	279.29M	183.22M	254.33M	119.91M
Total Growth		34.85%	52.44%	-27.96%	112.11%	15.18%

Source: S&P Global Market Intelligence.